New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 10, 2014
08:10 EDTRCPTReceptos risk/reward attractive following data, says Leerink
Leerink believes the Phase II data for RPC-1063 suggests the drug is meaningfully differentiated from other therapies in development at least for patients with relapsing forms of multiple sclerosis. The firm reiterates an Outperform rating on shares of Receptos with a $75 price target and views the risk/reward as attractive.
News For RCPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 30, 2015
09:26 EDTRCPTOn The Fly: Pre-market Movers
Subscribe for More Information
June 26, 2015
10:14 EDTRCPTOptions with decreasing implied volatility
Subscribe for More Information
June 19, 2015
10:27 EDTRCPTReceptos CFO says company has not canceled any events, Bloomberg reports
Subscribe for More Information
10:27 EDTRCPTReceptos calls active amid renewed takeover speculation
Subscribe for More Information
10:11 EDTRCPTReceptos did not cancel any conferences, says Evercore ISI
Evercore ISI commented on speculation that Receptos canceled out of conference and said the company has not canceled out of any brokers conferences.
10:08 EDTRCPTReceptos jumps amid continued takeover speculation
Speculation of a takeover is again taking shares of Receptos (RCPT) higher. The biopharma company, which has been frequently mentioned as a buyout candidate in blogs and analyst notes, is rumored to have canceled all of its conference appearances. The conference cancelations are unconfirmed, however, and itís not even clear if the company had any scheduled appearances. Further, while KYTHERA (KYTH) was recently acquired after canceling an appearance at a conference, such moves by companies often do not mean acquisition talks are underway. Shares of Receptos are well of their highs but remain up $1.94 to $189.06 in early trading.
09:49 EDTRCPTRumor: Receptos active amid renewed takeover speculation
Subscribe for More Information
June 18, 2015
09:22 EDTRCPTTheStreet's Feuerstein responds to Leerink note on Receptos
Subscribe for More Information
07:36 EDTRCPTReceptos remains an attractive takeover candidate, says Leerink
Subscribe for More Information
June 17, 2015
11:19 EDTRCPTInsider sales runs counter to Receptos takeover speculation, TheStreet reports
Subscribe for More Information
11:14 EDTRCPTLilly Ventures Fund sells 220,000 Receptos shares
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use